{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:07:08Z","timestamp":1791328028388,"version":"4.3.1"},"reference-count":27,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2011,9,23]],"date-time":"2011-09-23T00:00:00Z","timestamp":1316736000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Sporadic Creutzfeldt-Jakob disease (sCJD) is the commonest form of human prion diseases, accounting for about 85% of all cases. Current criteria for intra vitam diagnosis include a distinct phenotype, periodic sharp and slow-wave complexes at electroencephalography (EEG), and a positive 14-3-3-protein assay in the cerebrospinal fluid (CSF). In sCJD, the disease phenotype may vary, depending upon the genotype at codon 129 of the prion protein gene (PRNP), a site of a common methionine\/valine polymorphism, and two distinct conformers of the pathological prion protein. Based on the combination of these molecular determinants, six different sCJD subtypes are recognized, each with distinctive clinical and pathologic phenotypes. We analyzed CSF samples from 127 subjects with definite sCJD to assess the diagnostic value of 14-3-3 protein, total tau protein, phosphorylated181 tau, and amyloid beta (A\u03b2) peptide 1-42, either alone or in combination. While the 14-3-3 assay and tau protein levels were the most sensitive indicators of sCJD, the highest sensitivity, specificity and positive predictive value were obtained when all the above markers were combined. The latter approach also allowed a reliable differential diagnosis with other neurodegenerative dementias.<\/jats:p>","DOI":"10.3390\/ijms12096281","type":"journal-article","created":{"date-parts":[[2011,9,23]],"date-time":"2011-09-23T08:57:22Z","timestamp":1316768242000},"page":"6281-6292","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Cerebrospinal Fluid Markers in Sporadic Creutzfeldt-Jakob Disease"],"prefix":"10.3390","volume":"12","author":[{"given":"Gianluigi","family":"Zanusso","sequence":"first","affiliation":[{"name":"Section of Neuropathology, Department of Neurological, Neuropsychological, Morphological and Motor Sciences, University of Verona, Policlinico G.B. Rossi, Piazzale L.A. Scuro 10, 37134 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Fiorini","sequence":"additional","affiliation":[{"name":"Section of Neuropathology, Department of Neurological, Neuropsychological, Morphological and Motor Sciences, University of Verona, Policlinico G.B. Rossi, Piazzale L.A. Scuro 10, 37134 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Ferrari","sequence":"additional","affiliation":[{"name":"Section of Neuropathology, Department of Neurological, Neuropsychological, Morphological and Motor Sciences, University of Verona, Policlinico G.B. Rossi, Piazzale L.A. Scuro 10, 37134 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Gajofatto","sequence":"additional","affiliation":[{"name":"Section of Clinical Neurology, Department of Neurological, Neuropsychological, Morphological and Motor Sciences, University of Verona, Policlinico G.B. Rossi, Piazzale L.A. Scuro 10, 37134 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annachiara","family":"Cagnin","sequence":"additional","affiliation":[{"name":"Section of Neurology, Department of Neurosciences, University of Padova, Via Giustiniani 5, 35128 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Galassi","sequence":"additional","affiliation":[{"name":"Section of Legal Medicine, Department of Health Care Direction, San Bortolo General Hospital, Via Rodolfi 37, 36100 Vicenza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Richelli","sequence":"additional","affiliation":[{"name":"Section of Clinical Neurology, Department of Neurological, Neuropsychological, Morphological and Motor Sciences, University of Verona, Policlinico G.B. Rossi, Piazzale L.A. Scuro 10, 37134 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Monaco","sequence":"additional","affiliation":[{"name":"Section of Neuropathology, Department of Neurological, Neuropsychological, Morphological and Motor Sciences, University of Verona, Policlinico G.B. Rossi, Piazzale L.A. Scuro 10, 37134 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2011,9,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.2174\/092986706777585022","article-title":"Cerebral amyloidoses: molecular pathways and therapeutic challenges","volume":"13","author":"Monaco","year":"2006","journal-title":"Curr Med Chem"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/ana.410390613","article-title":"Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease","volume":"39","author":"Parchi","year":"1996","journal-title":"Ann Neurol"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"38936","DOI":"10.1074\/jbc.M405468200","article-title":"Identification of distinct n-terminal truncated forms of prion protein in different Creutzfeldt-Jakob disease subtypes","volume":"279","author":"Zanusso","year":"2004","journal-title":"J Biol Chem"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ddmec.2005.11.012","article-title":"Molecular mechanisms of human prion diseases","volume":"2","author":"Zanusso","year":"2005","journal-title":"Drug Discov Today: Dis Mech"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1212\/WNL.55.6.811","article-title":"Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-jakob disease","volume":"55","author":"Zerr","year":"2000","journal-title":"Neurology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1093\/brain\/awp191","article-title":"Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease","volume":"132","author":"Zerr","year":"2009","journal-title":"Brain"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0304-3940(97)00215-2","article-title":"Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease","volume":"225","author":"Otto","year":"1997","journal-title":"Neurosci Lett"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/sj.mp.4001220","article-title":"Phospho-tau\/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias","volume":"8","author":"Riemenschneider","year":"2003","journal-title":"Mol Psychiatr"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1212\/01.wnl.0000230159.67128.00","article-title":"CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease","volume":"67","author":"Green","year":"2006","journal-title":"Neurology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1468-1331.2006.01630.x","article-title":"CSF analysis in patients with sporadic CJD and other transmissible spongiform encephalopathies","volume":"14","author":"Green","year":"2007","journal-title":"Eur J Neurol"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1136\/jnnp.2009.197962","article-title":"The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review","volume":"81","author":"Chohan","year":"2010","journal-title":"J Neurol Neurosurg Psychiat"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJM199609263351303","article-title":"The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies","volume":"335","author":"Hsich","year":"1996","journal-title":"N Engl J Med"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1212\/01.WNL.0000160397.81314.84","article-title":"Phosphorylated 14-3-3zeta protein in the CSF of neuroleptic-treated patients","volume":"64","author":"Zanusso","year":"2005","journal-title":"Neurology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1212\/01.wnl.0000249150.98891.d1","article-title":"Detection of CSF 14-3-3 protein in Guillain-Barr\u00e9 syndrome","volume":"67","author":"Bersano","year":"2006","journal-title":"Neurology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neulet.2009.02.067","article-title":"The role of cerebrospinal fluid proteins as early diagnostic markers for sporadic Creutzfeldt-Jakob disease","volume":"455","author":"Pennington","year":"2009","journal-title":"Neurosci Lett"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/ana.21430","article-title":"Rapidly progressive dementia","volume":"64","author":"Geschwind","year":"2008","journal-title":"Ann Neurol"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/archneurol.2008.534","article-title":"Rapidly progressive neurodegenerative dementias","volume":"66","author":"Josephs","year":"2009","journal-title":"Arch Neurol"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1007\/s00415-009-5160-0","article-title":"Diagnostic value of CSF protein profile in a Portuguese population of sCJD patients","volume":"256","author":"Baldeiras","year":"2009","journal-title":"J Neurol"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/MAJ.0b013e3181e92a1f","article-title":"Elevated levels of tau protein in cerebrospinal fluid of patients with probable Creutzfeldt-Jakob disease","volume":"340","author":"Wang","year":"2010","journal-title":"Am J Med Sci"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00415-010-5738-6","article-title":"Tau and 14-3-3 of genetic and sporadic Creutzfeldt-Jakob disease patients in Israel","volume":"258","author":"Meiner","year":"2011","journal-title":"J Neurol"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1212\/WNL.58.2.192","article-title":"Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease","volume":"58","author":"Otto","year":"2002","journal-title":"Neurology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1474-4422(06)70355-6","article-title":"Association between CSF biomarkers and incipient Alzheimer\u2019s disease in patients with mild cognitive impairment: a follow-up study","volume":"5","author":"Hansson","year":"2006","journal-title":"Lancet Neurol"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1468-1331.2009.02595.x","article-title":"EFNS guidelines on disease-specific CSF investigations","volume":"16","author":"Deisenhammer","year":"2009","journal-title":"Eur J Neurol"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1136\/jnnp.74.9.1210","article-title":"A prospective study of CSF markers in 250 patients with possible Creutzfeldt-Jakob disease","volume":"74","author":"Quoilin","year":"2003","journal-title":"J Neurol Neurosurg Psychiat"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.neurobiolaging.2008.01.007","article-title":"14-3-3 CSF levels in sporadic Creutzfeldt-Jakob disease differ across molecular subtypes","volume":"30","author":"Heinemann","year":"2009","journal-title":"Neurobiol Aging"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1212\/01.WNL.0000135153.96325.3B","article-title":"Sensitivity of 14-3-3 protein test varies in subtypes of sporadic Creutzfeldt-Jakob disease","volume":"63","author":"Castellani","year":"2004","journal-title":"Neurology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/ana.20477","article-title":"Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer\u2019s disease","volume":"57","author":"Grossman","year":"2005","journal-title":"Ann Neurol"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/12\/9\/6281\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:57:29Z","timestamp":1760219849000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/12\/9\/6281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,23]]},"references-count":27,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2011,9]]}},"alternative-id":["ijms12096281"],"URL":"https:\/\/doi.org\/10.3390\/ijms12096281","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,23]]}}}